AMRX

AMRX

USD

Amneal Pharmaceuticals Inc. Class A Common Stock

$11.350+0.340 (3.088%)

实时价格

Healthcare
Drug Manufacturers - Specialty & Generic
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$11.010

最高价

$11.400

最低价

$10.940

成交量

3.47M

公司基本面

市值

3.6B

所属行业

Drug Manufacturers - Specialty & Generic

国家/地区

United States

交易统计

平均成交量

1.66M

交易所

NMS

货币

USD

52周价格范围

最低价 $6.685当前价 $11.350最高价 $11.4

相关新闻

Analyst Upgrades

Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13

Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.

查看更多
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
GlobeNewswire

Amneal Reports Third Quarter 2025 Financial Results

‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,

查看更多
Amneal Reports Third Quarter 2025 Financial Results
GlobeNewswire

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's

查看更多